L3MBTL3 Activators encompass a group of chemicals specifically designed to target and indirectly influence the functionality of the L3MBTL3 protein. These activators operate on the principle of mediating chromatin remodeling and epigenetic alterations, thus indirectly influencing L3MBTL3's role. One of the standout features of this chemical class is their ability to modulate chromatin structure by altering DNA methylation and histone modification patterns. For instance, compounds like 5-Azacytidine, a DNA methyltransferase inhibitor, can promote DNA hypomethylation, which in turn has implications for chromatin structure and can affect L3MBTL3's activity. Similarly, Trichostatin A and SAHA, both histone deacetylase inhibitors, enhance histone acetylation, leading to a more open chromatin structure which can modulate the function of L3MBTL3.
Additionally, several members of this chemical class focus on modifying histone methylation patterns, another critical facet of chromatin dynamics. Agents such as BIX-01294 and EPZ-6438 inhibit specific histone methyltransferases, thereby altering histone methylation status. Such alterations can impact the chromatin environment and have downstream effects on L3MBTL3. Other compounds like JQ1, a BET bromodomain inhibitor, function by influencing transcription through modifying chromatin interactions, which may subsequently affect L3MBTL3.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that causes DNA hypomethylation and can potentially affect chromatin structure, indirectly influencing L3MBTL3 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that promotes histone acetylation and opens up chromatin structure. This change can indirectly modulate L3MBTL3 function. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor that enhances histone acetylation, potentially affecting L3MBTL3's activity. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
An inhibitor of G9a histone methyltransferase. Changes in histone methylation patterns can indirectly influence L3MBTL3. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
A selective inhibitor of EZH2 histone methyltransferase. By modifying histone methylation status, it can indirectly affect L3MBTL3. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor that influences transcription through modifying chromatin interactions. This may have downstream effects on L3MBTL3. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
A specific HDAC3 inhibitor that alters chromatin acetylation patterns, potentially affecting L3MBTL3's function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A class I histone deacetylase inhibitor. By modulating acetylation levels, it can indirectly influence L3MBTL3. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
An inhibitor of EZH1/EZH2 histone methyltransferases. Changes in chromatin methylation can indirectly influence L3MBTL3. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
A p300 histone acetyltransferase inhibitor. By altering acetylation patterns, it might modulate L3MBTL3's activity. | ||||||